Literature DB >> 28526535

TNF-α is superior to conventional inflammatory mediators in forecasting IVIG nonresponse and coronary arteritis in Chinese children with Kawasaki disease.

Peng Hu1, Guang Mei Jiang2, Yue Wu2, Bao Yu Huang2, Si Yan Liu2, Dong Dong Zhang2, Yao Xu2, Yang Fang Wu2, Xun Xia2, Wei Wei2, Bo Hu2.   

Abstract

BACKGROUND: Tumor necrosis factor (TNF) -α is of inflammatory cytokines produced chiefly by activated monocyte/macrophages, and has been implicated in the pathogenesis of Kawasaki disease (KD). We elucidated the relationship of plasma TNF-α with conventional inflammatory mediators, clinical classification, intravenous immunoglobulin (IVIG) response and coronary arteritis in the course of KD.
METHODS: Seventy Chinese children with KD were enrolled and divided into 6 subgroups, including complete KD, incomplete KD, IVIG-responsive KD, IVIG-nonresponsive KD, coronary artery (CA) -noninvolvement KD and CA-involvement KD. Blood samples were collected from all subjects at 24h pre- and 48h post-IVIG therapy, respectively. TNF-α, white blood cells counts (WBC), absolute neutrophil counts (ANC), C-reactive protein (CRP), erythrocyte sedimentation rate (ESR) and procalcitonin (PCT) were detected.
RESULTS: Plasma TNF-α markedly increased in the acute phase of KD and was positively correlated with CRP and PCT, whereas remained high after IVIG therapy. TNF-α as well as conventional inflammatory mediators could not be used to differentiate the clinical classification of KD, but they may prove beneficial to heighten or reduce the suspicion of incomplete KD. Plasma TNF-α was significantly higher in both IVIG-nonresponsive patients and coronary arteritis patients, but no significant differences were observed in all the other inflammatory mediators. Moreover, plasma TNF-α was positively correlated with the internal diameter of CA.
CONCLUSIONS: TNF-α is superior to conventional inflammatory mediators in forecasting IVIG nonresponse and coronary arteritis in Chinese children with KD.
Copyright © 2017. Published by Elsevier B.V.

Entities:  

Keywords:  Coronary arteritis; Intravenous immunoglobulin; Kawasaki disease; Tumor necrosis factor-α; Vascular endothelial cell

Mesh:

Substances:

Year:  2017        PMID: 28526535     DOI: 10.1016/j.cca.2017.05.019

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  13 in total

1.  Sphk1 promotes ulcerative colitis via activating JAK2/STAT3 signaling pathway.

Authors:  Jiawen Liu; Bo Jiang
Journal:  Hum Cell       Date:  2019-10-12       Impact factor: 4.174

2.  Anti-Inflammatory Effects of Gingerol on Lipopolysaccharide-Stimulated RAW 264.7 Cells by Inhibiting NF-κB Signaling Pathway.

Authors:  Na Liang; Yaxin Sang; Weihua Liu; Wenlong Yu; Xianghong Wang
Journal:  Inflammation       Date:  2018-06       Impact factor: 4.092

3.  Hepatic dysfunction secondary to Kawasaki disease: characteristics, etiology and predictive role in coronary artery abnormalities.

Authors:  Goshgar Mammadov; Hui Hui Liu; Wei Xia Chen; Guo Zhen Fan; Rui Xue Li; Fei Fei Liu; Sama Samadli; Jing Jing Wang; Yang Fang Wu; Huang Huang Luo; Dong Dong Zhang; Wei Wei; Peng Hu
Journal:  Clin Exp Med       Date:  2019-11-16       Impact factor: 3.984

Review 4.  Perspective of Immunopathogenesis and Immunotherapies for Kawasaki Disease.

Authors:  Lung Chang; Horng-Woei Yang; Tang-Yu Lin; Kuender D Yang
Journal:  Front Pediatr       Date:  2021-07-19       Impact factor: 3.418

5.  Utility of Soluble CD163 in the Clinical Management of Patients With Kawasaki Disease.

Authors:  Yoshihiro Azuma; Yasuo Suzuki; Seigo Okada; Chie Matsuguma; Hiroyuki Wakiguchi; Yuji Ohnishi; Takashi Furuta; Akiko Miyake; Hiroki Yasudo; Kiyoshi Ichihara; Shouichi Ohga; Shunji Hasegawa
Journal:  Front Pediatr       Date:  2020-04-07       Impact factor: 3.418

6.  Comparison of second-line therapy in IVIg-refractory Kawasaki disease: a systematic review.

Authors:  Courtney B Crayne; Chace Mitchell; Timothy Beukelman
Journal:  Pediatr Rheumatol Online J       Date:  2019-11-27       Impact factor: 3.054

7.  A New Scoring System for Prediction of Intravenous Immunoglobulin Resistance of Kawasaki Disease in Infants Under 1-Year Old.

Authors:  Shu Wu; Yuan Long; Selena Chen; Yaqian Huang; Ying Liao; Yan Sun; Qingyou Zhang; Chunyu Zhang; Hui Yan; Jianguang Qi; Xueqin Liu; Yonghong Chen; Yong Zhang; Junbao Du
Journal:  Front Pediatr       Date:  2019-12-11       Impact factor: 3.418

8.  Usefulness of Kawasaki disease risk scoring systems to the Turkish population.

Authors:  Kazım Öztarhan; Yusuf Ziya Varlı; Nuray Aktay Ayaz
Journal:  Anatol J Cardiol       Date:  2020-08       Impact factor: 1.596

9.  Serum exosomal miR-328, miR-575, miR-134 and miR-671-5p as potential biomarkers for the diagnosis of Kawasaki disease and the prediction of therapeutic outcomes of intravenous immunoglobulin therapy.

Authors:  Xiaofei Zhang; Guangda Xin; Dajun Sun
Journal:  Exp Ther Med       Date:  2018-07-17       Impact factor: 2.447

Review 10.  Kawasaki syndrome: role of superantigens revisited.

Authors:  Donald Y M Leung; Patrick M Schlievert
Journal:  FEBS J       Date:  2020-08-24       Impact factor: 5.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.